TxSphere designed its technology to deliver drugs at a higher volume and higher viscosity than traditional autoinjectors.

Study met primary end point and demonstrated successful subcutaneous administration of a 10 mL biologic co-formulated with ENHANZE® in 30 seconds using Halozyme's proprietary high-volume auto-injector ...

Celltrion said on the 18th that the Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) recommended approval of a variation application to add an ...